tiprankstipranks
Bausch + Lomb Debuts Eye Health Innovations
Company Announcements

Bausch + Lomb Debuts Eye Health Innovations

Bausch + Lomb Corporation (BLCO) has released an update.

Bausch + Lomb Corporation is set to present 21 posters at the Association for Research in Vision and Ophthalmology Annual Meeting, showcasing studies on their eye care products, including a novel dry eye supplement, Blink™ NutriTears®. The presentations will cover a range of topics from consumer eye care to pharmaceutical and surgical innovations. This display of research underscores Bausch + Lomb’s commitment to advancing eye health knowledge and introducing new solutions for both professionals and consumers.

For further insights into BLCO stock, check out TipRanks’ Stock Analysis page.

Related Articles
TheFlyBausch + Lomb initiated with an Outperform at Raymond James
TheFlyBausch + Lomb price target raised to $15.50 from $15 at Evercore ISI
TipRanks Canadian Auto-Generated NewsdeskBausch + Lomb Showcases Innovations at EuDEC 2024
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Optimize your mobile reading experience. Download the TipRanks App today!